Related Experiment Video
Updated: May 25, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
The Pathogenesis of Inflammatory Bowel Diseases
Gaurav Chauhan1, Florian Rieder2
1Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Inflammatory bowel diseases (IBDs) involve immune system dysregulation and environmental factors, leading to chronic intestinal inflammation. Understanding these mechanisms is key to developing new treatments for IBD.
Area of Science:
- Gastroenterology
- Immunology
- Pathogenesis
Background:
- Inflammatory bowel diseases (IBDs) are chronic conditions characterized by relapsing, remitting intestinal inflammation.
- Genetic and environmental factors, including the microbiome, contribute to IBD development.
- IBD pathogenesis involves complex interactions between innate and adaptive immune systems.
Purpose of the Study:
- To summarize the key pathogenic mechanisms underlying inflammatory bowel diseases.
- To highlight the roles of immune dysregulation and environmental factors in IBD.
- To provide an overview of the molecular and cellular processes involved in IBD.
Main Methods:
- Review of existing literature on IBD pathogenesis.
- Analysis of findings from familial aggregation and genome-wide association studies.
- Synthesis of information on innate and adaptive immune responses in IBD.
Main Results:
- IBD involves dysregulation of both innate immunity (intestinal barrier, ER stress, microbial recognition) and adaptive immunity (cytokines, T cells, leukocyte migration).
- Environmental factors, particularly the gut microbiome, interact with genetic predispositions.
- Abnormal wound healing and fibrosis are associated with IBD pathogenesis.
Conclusions:
- IBD pathogenesis is multifactorial, involving genetic susceptibility, immune system dysregulation, and environmental triggers.
- Understanding these mechanisms is crucial for developing targeted therapies for inflammatory bowel diseases.
- Further research into immune pathways and microbiome interactions can lead to improved IBD management.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...